Status:
UNKNOWN
Tamsulosin for Thyroid Lid Retraction
Lead Sponsor:
Sheba Medical Center
Conditions:
Thyroid Eye Disease
Eyelid Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine the effect of using Tamsulosin for treatment of eyelid retraction as part of thyroid eye disease. The treatment will be offered to all thyroid patients sufferin...
Detailed Description
Thyroid eye disease is a common autoimmune disorder caused by antibodies directed against receptors present in the thyroid cells and extra-ocular muscles and soft tissue of the orbit. The disorder is ...
Eligibility Criteria
Inclusion
- Thyroid eye disease patients suffering from upper eyelid retraction in one or both eyes
Exclusion
- pregnant/breastfeeding women
- previous eyelid surgery/trauma
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04359979
Start Date
May 1 2020
End Date
December 1 2023
Last Update
June 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Tel Litwinsky, Israel